Yazar "Uzuner N." seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Analyses of the Turkish National Intravenous Thrombolysis Registry(W.B. Saunders, 2016) Kutluk K.; Kaya D.; Afsar N.; Arsava E.M.; Ozturk V.; Uzuner N.; Giray S.; Topcuoglu M.A.; Gungor L.; Sirin H.; Yaka E.; Ozdemir O.; Dalkara T.Background The relatively late approval of use of recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke in Turkey has resulted in obvious underuse of this treatment. Here we present the analyses of the nationwide registry, which was created to prompt wider use of intravenous thrombolysis, as well as to monitor safe implementation of the treatment in our country. Methods Patients were registered prospectively in our database between 2006 and 2013. Admission and 24-hour National Institutes of Health Stroke Scale and 3-month modified Rankin Scale scores were recorded. A "high-volume center" was defined as a center treating 10 or more patients with rt-PA per year. Results A total of 1133 patients were enrolled into the registry by 38 centers in 18 cities. A nearly 4-fold increase in the study population and in the number of participating centers was observed over the 6 years of the study. The mean baseline NIHSS score was 14.5 ± 5.7, and the prevalence of symptomatic hemorrhage was 4.9%. Mortality at 3 months decreased from 22% to 11% in the 6 years of enrollment, and 65% of cases were functionally independent. Age older than 70 years, an NIHSS score higher than 14 upon hospital admission, and intracranial hemorrhage were independently associated with mortality, and being treated in a high-volume center was related to good outcome. Conclusions We observed a decreasing trend in mortality and an acceptable prevalence of symptomatic hemorrhage over 6 years with continuous addition of new centers to the registry. The first results of this prospective study are encouraging and will stimulate our efforts at increasing the use of intravenous thrombolysis in Turkey. © 2016 National Stroke Association.Öğe Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma(2008) Olmez D.; Babayigit A.; Uzuner N.; Erbil G.; Karaman O.; Yilmaz O.; Cetin E.O.; Ozogul C.Sulphasalazine is a specific inhibitor of nuclear factor kappa B (NF-? B) which plays a key role in asthma. To determine the impact of sulphasalazine in the treatment of chronic asthma, BALB/c mice were sensitized and challenged with ovalbumin. Mice with experimentally induced asthma in group I received saline, group II sulphasalazine 200 mg/kg, group III sulphasalazine 300 mg/kg, and group IV dexamethasone 1 mg/kg intraperitoneally once a day in the last 7 days of the challenge period. Histological findings of the airways were evaluated by light and electron microscopies. Dexamethasone and sulphasalazine in both doses significantly improved all airway histopathologic parameters of asthma except numbers of goblet cells. Both doses of sulphasalazine improved thicknesses of basement membrane better than dexamethasone. Dexamethasone reduced the number of mast cells better than sulphasalazine (200 mg/kg). Further studies are needed to evaluate the efficacy of sulphasalazine in the treatment of asthma. Copyright © Informa Healthcare USA, Inc.Öğe Ginseng ameliorates chronic histopathologic changes in a murine model of asthma(2008) Babayigit A.; Olmez D.; Karaman O.; Bagriyanik H.A.; Yilmaz O.; Kivcak B.; Erbil G.; Uzuner N.Currently, asthma therapies are effective in reducing inflammation but airway remodeling is poorly responsive to these agents. New therapeutic options that have fewer side effects and reverse chronic changes in the lungs are essential. This study aimed to determine the efficacy of oral administration of ginseng on lung histopathology in a murine model of chronic asthma. BALB/c mice were divided into four groups: control, placebo, ginseng, and dexamethasone. All mice except those in the control group were sensitized and challenged with ovalbumin. Then, mice in the ginseng group were given 2 gr/kg per day of ginseng and mice in the dexamethasone group received 1 mg/kg per day of dexamethasone via orogastic gavage once daily for 1 week. Lung histopathology was evaluated by using light and electron microscopy in all groups. All of the chronic changes of airways in the ginseng group were significantly ameliorated when compared with the placebo group. When compared with the dexamethasone group, the ginseng group had significantly lower numbers of mast cell count. Thicknesses of basement membrane, epithelium, and subepithelial smooth muscle were not statistically different between the ginseng and dexamethasone groups. Goblet cell numbers were much more reduced in the dexamethasone group. Ginseng is effective in resolving the established chronic histopathological changes of the lungs in the murine model of asthma. Copyright © 2008, OceanSide Publications, Inc., U.S.A.Öğe Management of complications and intensive care: Guidelines of Turkish Society of Cerebrovascular Diseases 2015 [Komplikasyonlarin tedavisi ve yogun bakim: türk beyin damar hastaliklari dernegi inme tani ve tedavi kilavuzu 2015](Turkish Society of Cerebrovascular Diseases, 2015) Güler A.; Turgut N.; Topaktas S.; Topçuoglu M.A.; Sirin H.; Kocaman A.S.; Kutluk K.; Uzuner N.Clinical detoriation in ischemic stroke patients may develop because of several reasons. Deterioration may be caused by a recurrent brain infarction or cerebral hemorrhage. But increased intracranial pressure, infections especially pulmonary infections, embolic events, complications due to respiratory and feeding problems can cause worsening in clinical picture.Öğe (Un)Awareness of allergy(BioMed Central Ltd., 2011) Kalpaklioglu A.F.; Kalkan I.K.; Akcay A.; Reisli I.; Can D.; Uzuner N.; Yuksel H.; Kirmaz C.; Gulen F.; Ediger D.Background: Allergy is associated with considerable morbidity. Objective: The aim of this multicenter study was to provide insight into allergy knowledge and perceptions among the population. Methods: During the World Allergy Day, several allergy clinics conducted public meetings to encourage the awareness of and education in allergy. At the beginning, participants filled out a questionnaire to assess their knowledge about what is allergy and to determine by whom those symptoms are cared. Results: A total of 256 participants (187 women/69 men, mean age, 31.2 ± 12.5 years) completed the survey. Of the 202 participants with symptoms, 58.9% had physician-diagnosed allergic disease. Among the 19 symptoms evaluated, 56.5% of the symptoms were recognized as related with allergy, and this increased in compliance with education level (r = +0.427; P < 0.001) but not with diagnosed allergy (P = 0.34). Sneezing was the most common symptom thought to be related with allergy-related symptom (77.5%), whereas loss of smell was the least one (37.9%). Participants were more likely to be cared by an allergologist (72.9%) followed by other specialties, when experiencing allergy. Conclusions: Increasing the awareness for allergic symptoms is the key not only for the diagnosis but also for the optimal treatment. Therefore, education is an important component of prevention and control of allergic diseases. Copyright © 2011 by World Allergy Organization.
